Skip to content

Active ingredient

Fosaprepitant

27 finished FDA listings contain Fosaprepitant as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
FOSAPREPITANT DIMEGLUMINE
Dosage forms
Injection, Injection, Powder, Lyophilized, For Solution
Routes
Intravenous
Manufacturers / labelers
21
Strengths listed
150 mg/1 · 150 mg/50ml · 150 mg/5ml
Brand names in FDA listings
Emend, Focinvez, Fosaprepitant, Navitrux

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 1731071

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 022023MERCK AND CO INC2008-01-251
ANDA 206197FRESENIUS KABI USA2016-06-091
NDA 210064TEVA PHARMS USA2019-09-051
ANDA 211860BAXTER HLTHCARE CORP2019-09-051
ANDA 212309BE PHARMS2019-09-051
ANDA 204015MYLAN LABS LTD2019-09-051
ANDA 205020APOTEX2019-09-051
ANDA 209965MSN2019-09-057
ANDA 213106QILU PHARM HAINAN2020-09-083
ANDA 211160DR REDDYS2020-12-091
ANDA 210625EUGIA PHARMA2021-01-121
ANDA 212143CHIA TAI TIANQING2021-03-032
ANDA 214616ASPIRO2021-07-293
NDA 216686STERISCIENCE2023-08-222
NDA 220436AVYXA HOLDINGS2026-06-241

Official labeling on DailyMed

Showing the 12 most recent of 26 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.